Which tests are included in hypertensive retinopathy testing?

Which tests are included in hypertensive retinopathy testing?

• A. Fundus photography, blood pressure, OCT-A, and intravenous fluorescein angiography
• B. Blood sugar testing and lipids
• C. OCTA alone
• D. Fundus photography and visual field testing

Answer: (A)

Hypertensive retinopathy evaluation relies on both documenting retinal vascular changes and monitoring systemic blood pressure, because the retinal findings reflect the level and duration of blood pressure elevation. Fundus photography is essential for a permanent record of signs such as arteriolar narrowing, copper/silver wiring, AV nicking, hemorrhages, exudates, and cotton-wool spots. Measuring the patient’s blood pressure is crucial to gauge severity and guide management, since systemic control directly impacts retinal status. Imaging the microvasculature adds depth to the assessment. OCT-A provides a noninvasive view of the retinal capillary networks, highlighting microvascular changes that accompany hypertensive damage. Intravenous fluorescein angiography offers dynamic visualization of leakage, nonperfusion, and vascular integrity, which can be particularly informative in ambiguous cases or when other retinal diseases are suspected. Other options rely on tests not specific to hypertensive retinopathy or omit key imaging. For example, blood sugar testing and lipids pertain more to diabetic or cardiovascular risk screening than to hypertensive retinal changes; OCT-A alone lacks the functional and systemic context; and fundus photography with visual field testing adds a functional assessment not routinely needed to characterize hypertensive retinal pathology.

Hypertensive retinopathy evaluation relies on both documenting retinal vascular changes and monitoring systemic blood pressure, because the retinal findings reflect the level and duration of blood pressure elevation. Fundus photography is essential for a permanent record of signs such as arteriolar narrowing, copper/silver wiring, AV nicking, hemorrhages, exudates, and cotton-wool spots. Measuring the patient’s blood pressure is crucial to gauge severity and guide management, since systemic control directly impacts retinal status.

Imaging the microvasculature adds depth to the assessment. OCT-A provides a noninvasive view of the retinal capillary networks, highlighting microvascular changes that accompany hypertensive damage. Intravenous fluorescein angiography offers dynamic visualization of leakage, nonperfusion, and vascular integrity, which can be particularly informative in ambiguous cases or when other retinal diseases are suspected.

Other options rely on tests not specific to hypertensive retinopathy or omit key imaging. For example, blood sugar testing and lipids pertain more to diabetic or cardiovascular risk screening than to hypertensive retinal changes; OCT-A alone lacks the functional and systemic context; and fundus photography with visual field testing adds a functional assessment not routinely needed to characterize hypertensive retinal pathology.